Searchable abstracts of presentations at key conferences in endocrinology

ea0038p69 | Clinical practice/governance and case reports | SFEBES2015

Endometrial hyperplasia in transmen: to scan or not to scan?

Seal Leighton , Middleton Iffy , Barrett James

Endometrial hyperplasia has been reported in up to 15% of transmen. For this reason the current clinical practice suggest that the uterus should be scanned every 2 years.This is the single centre retrospective audit study at the largest UK Gender Identity Clinic to examine the incidence of endometrial hyperplasia in transmen.Between 2006 and 2012. 200 patients having been maintained on testosterone therapy for 2 years, of those 108...

ea0038p183 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Gender-related differences in circulating microparticles characteristics: implications for cardiovascular risk?

Witczak Justyna , Rees Aled , James Philip

Introduction: Microparticles (MP) are circulating submicron particles released from cell membranes. They have an important role in intercellular endocrine signalling and may be increased in numerous conditions including cardiovascular disease. However, the influences of gender on MP characteristics are not fully understood.Aim: To compare MP characteristics (size, concentration, cellular origin and inflammatory profile) in healthy males and females acros...

ea0038p380 | Reproduction | SFEBES2015

Self medication in transpeople is not associated with deterioration in cardiovascular risk factors but is associated with reduced vitamin D levels and antidepressant use

Seal Leighton , Khaleque Fahmin , Barrett James

Objective: This is a prospective audit looking at cardiovascular parameters in transpeople comparing those who have self medicated verses those who have not.Methods: Patients attending a workshop for new patients were questioned about cardiovascular risk factors including diabetes hypertension and smoking status. Measurements were made of lipid profile, glucose, blood pressure, waist, height and weight measurement. Those that were self medicating (SM) we...

ea0037ep963 | Thyroid (non-cancer) | ECE2015

Beware Carbimazole induced agranulocytosis in amiodarone induced thyrotoxicosis: recovery with Filgrastim

O'Hare James , Sebatian Alwin , Casserly Liam

Agranuloctosis is a rare and serious complication of Carbimazole. (risk <1/106 of population/year. It is associated with higher doses. We report two cases over 1 year in patients exposed to amiodarone.Case 1: A 63 year old man with ischemic cardiomyopathy had been treated with amiodarone for atrial fibrillation for 3 years. 6 months after stopping he developed symptomatic thyrotoxicosis and started on carbimazole 60 mg per day. Thyroid T<s...

ea0036oc7.3 | Oral Communications 7 | BSPED2014

Do diabetes teams give consistent advice on self-management and does it relate to glycaemic control? Yorkshire and Humber Paediatric Diabetes network survey

Niranjan Usha , West James , Price Katherine

Objectives: Glycaemic targets set by diabetes teams appear to have an impact on glycaemic control. Our objective was to identify if there is consensus between and within teams in our network on glycaemic targets and whether this correlates with HbA1c outcomes.Methods: An online survey was sent to all network members requesting an independent response on the diabetes self-management advice given to families. Three patient groups were considered: children ...

ea0035oc6.3 | Bone, calcium &amp; vitamin D | ECE2014

Hypoparathyroidism: The burden of illness and impact on patients' personal lives

Clarke Bart , Sanders James , Lagast Hjalmar

Hypoparathyroidism, a rare endocrine disorder of insufficient parathyroid hormone, leads to hypocalcemia and often hyperphosphatemia. The PARADOX study assessed the clinical and personal disease impact from the affected patients’ perspective.Patients ≥18 years and diagnosed ≥6 months ago completed a non-validated, self-reported, web-based survey.Three hundred and seventy-four US adults (mean age, 49 years; women, 8...

ea0031p172 | Neoplasia, cancer and late effects | SFEBES2013

Gut carcinoid in a patient with horseshoe kidney and family history of carcinoid syndrome: a case report

Lois Konstantinos , James Andy , Perros Petros

Introduction: The familial risks of carcinoids are not clear. There has never been a report of gastrointestinal carcinoid coexisting with horseshoe kidney.Case presentation: We present the case of a 15 mm well differentiated metastatic small bowel NET with vascular and perineural invasion and three of four positive lymph nodes (Ki67: 1.9%, ENETS stage: pT4 pN1 pMX R1) in a 75-year-old British male with episodes of diarrhea and 24 h urinary 5HIAA: 48 (&#6...

ea0028s6.4 | Inhibiting steroid enzymes to treat common diseases | SFEBES2012

Potential prostate cancer drug therapy targets bioactivation of androstanediol to dihydrotestosterone

Mohler James , Titus Mark , Wilson Elizabeth

Prostate cancer development and progression depend on androgen signaling through the androgen receptor (AR). Recent evidence indicates the continued presence of intratumoral dihydrotestosterone (DHT) during androgen deprivation therapy drives prostate cancer recurrence through the activation of AR. There are ongoing efforts to identify drugs that target AR and enzymes that catalyze the synthesis of testosterone and DHT. Temporary remediation of prostate cancer by surgical or m...

ea0027p72 | (1) | BSPED2011

Which test to use for screening glucose intolerance in overweight/obese children?

O'Riordan Stephen , Greening James , Shenoy Savitha

Background: With the increasing prevalence of obesity and related morbidity including glucose intolerance in childhood, there remains a dispute about the best screening test to identify this early. The aim of our study was to determine the prevalence of impaired glucose tolerance (IGT)/type 2 diabetes mellitus (T2DM) in a multiethnic cohort of 100 overweight/obese children and adolescents in our clinic and compare the results of the screening tests.Study...

ea0025p61 | Clinical biochemistry | SFEBES2011

Life-threatening adverse reaction following pituitary MRI

Achilleos Katerina , Irani Tehmina , Ahlquist James

Pituitary MRI is widely used in endocrine practice, and is regarded as entirely safe. We report here a life-threatening outcome from a routine pituitary MRI scan.A 23-year-old female with a 3-year history of microprolactinoma confirmed by MRI underwent a routine repeat MRI scan with gadolinium. During injection of Gadovist she experienced minimal chest tightness which rapidly resolved. Four hours after the injection she rapidly became very breathless. On...